Stock screener

STOK

Conviction 28HealthcareScan · Thu, Sep 24, 2026

Stoke Therapeutics, Inc. (STOK) closed at $25.27 (-3.24%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 30, RS Rating 51, -34.1% from its 52-week high, -18.2% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

STOK$25.27-3.24%
ResistanceSupportVol 14Insider sell
63 bars
6
Vol MA14 934.5K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Stoke Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.stoketherapeutics.com ↗
Price25.27
Change-3.24%
Gap+0.33%
Rel volume3.56×
Avg volume888.18K
Avg $ vol25.54M
SMA 2029.33
SMA 5030.29
SMA 20031.86
Price vs 50-16.60%
Price vs 200-20.71%
MA stackbearish
50/200 cross—
Supertrenddown · 29.86
RSI (14)30
MACD hist-0.37
MACD cross—
Stoch %K / %D4 / 14
ADX (14)23
+DI / −DI13 / 34
RSI divergence—
MACD divergence—
ATR %5.63%
ADR %4.43%
52w high38.35
52w low22.37
From 52w high-34.12%
Above 52w low+12.94%
New 52w highNo
SqueezeOff
Bollinger width23.18%
%B-0.10
Donchian pos3.00%
Donchian high33.18
Donchian low25.02
AVWAP (52w high)31.55
vs AVWAP high-19.92%
AVWAP (52w low)31.22
vs AVWAP low-19.09%
OBV trendDown
Chaikin MF (20)-0.24
Today vs 20d3.56×
Avg vol (14d)934.5K
Avg vol (20d)888.18K
Avg $ vol (20d)25.54M
Market cap1.63B
RS Rating51 / 99
RS 3m (vs SPY)-21.38%
RS 6m (vs SPY)-42.05%
RS line new highNo
Trend template2/8
Technical rank12.2
1 week-12.67%
1 month-24.49%
3 months-16.89%
6 months-25.23%
1 year+11.64%
YTD-18.24%
P/E-236.78
P/B4.72
P/S8.84
P/FCF36.30
EPS-0.1200
Div yield—
ROE-1.99%
ROA-1.75%
Debt/Eq—
Current7.69
EV/EBITDA—
Gross margin—
Net margin-3.73%
Rev growth404.50%
EPS growth92.26%
Price target45.40
Target upside79.70%
Analyst ratingBuy
Institutional129.04%
Ent. value1.52B
Revenue9.32M
Net income-61.62M
Gross profit—
Free cash flow44.91M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out62.28M
Employees170
ListedWed, Jun 19, 2019
Free float49.14M
Float %86.0%
Short interest11.2M
Days to cover11.9d
Short volume58.1%
Squeeze score92 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.93 vs −$0.82
Last surprise-13.4% miss
Setup gradeD
Conviction28 / 100
Pattern quality—
Tech rank12.2 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance33.75
Support27.93
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in STOK

All disclosures →
No recent disclosed trades by Congress in STOK. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in STOK · open-market 6 sells

InsiderSideShares
Ticho Barry
CHIEF MEDICAL OFFICER · Common Stock · 2026-08-18
Sell4.53K
Kaye Edward M. MD
Director · Common Stock · 2026-08-18
Sell637
Allan Jonathan
GENERAL COUNSEL & CORP SEC · Common Stock · 2026-08-18
Sell2.72K
Allan Jonathan
GENERAL COUNSEL & CORP SEC · Common Stock · 2026-08-18
Sell145
Ticho Barry
CHIEF MEDICAL OFFICER · Common Stock · 2026-08-18
Sell242
Kaye Edward M. MD
Director · Common Stock · 2026-08-18
Sell11.93K
Kaye Edward M. MD
Director · Common Stock · 2026-08-14
Exercise26.25K
Kaye Edward M. MD
Director · Performance Stock Units · 2026-08-14
Exercise26.25K
Allan Jonathan
GENERAL COUNSEL & CORP SEC · Common Stock · 2026-08-14
Exercise6K
Ticho Barry
CHIEF MEDICAL OFFICER · Common Stock · 2026-08-14
Exercise10K

SEC filings

EDGAR filings in STOK · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.